美国心脏协会科学声明:球囊肺动脉成形术在慢性血栓栓塞性肺病中的应用现状与未来方向
该科学声明由美国心脏协会发布,针对伴或不伴肺动脉高压的慢性血栓栓塞性肺病患者,阐述球囊肺动脉成形术的应用现状。声明指出欧洲心脏病学会指南已对该技术用于无法手术及残留性慢性血栓栓塞性肺动脉高压给出1类推荐,但领域缺乏关于人员资质、患者选择、术前规划及疗效安全评估标准的共识,故提供专家共识意见并指明知识空白与研究方向。
要点
- 欧洲指南对无法手术和残留性慢性血栓栓塞性肺动脉高压的球囊肺动脉成形术给出1类推荐。
- 当前缺乏人员资质、患者选择、术前规划及疗效安全评估的标准化共识。
- 声明为有意开展该技术的新中心提供指导并指出未来研究方向。
核心结论
- 球囊肺动脉成形术正成为伴或不伴肺动脉高压的慢性血栓栓塞性肺病的治疗选择,但需建立标准化共识以规范临床实践。
研究设计与样本
- 美国心脏协会发布的科学声明,由关键意见领袖共同撰写,总结现状并提供共识意见。
主要发现
- 欧洲心脏病学会指南对无法手术和残留性慢性血栓栓塞性肺动脉高压的球囊肺动脉成形术给出1类推荐。
- 慢性血栓栓塞性肺动脉高压中心正快速启动球囊肺动脉成形术项目。
- 球囊肺动脉成形术技能目前主要通过同行接触和培训学习。
关键数值与推荐
- 欧洲心脏病学会指南对无法手术和残留性慢性血栓栓塞性肺动脉高压的球囊肺动脉成形术推荐级别为1类。
临床怎么用
- 声明提供关于必要人员与专业知识、患者选择标准、术前规划标准化方法以及疗效与安全性评估标准的共识意见。
- 为有兴趣启动球囊肺动脉成形术项目的新中心提供指导。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension. Recent European Society of Cardiology guidelines on pulmonary hypertension now give balloon pulmonary angioplasty a Class 1 recommendation for inoperable and residual chronic thromboembolic pulmonary hypertension. Not surprisingly, chronic thromboembolic pulmonary hypertension centers are rapidly initiating balloon pulmonary angioplasty programs. However, we need a comprehensive, expert consensus document outlining critical concepts, including identifying necessary personnel and expertise, criteria for patient selection, and a standardized approach to preprocedural planning and establishing criteria for evaluating procedural efficacy and safety. Given this lack of standards, the balloon pulmonary angioplasty skill set is learned through peer-to-peer contact and training. This document is a state-of-the-art, comprehensive statement from key thought leaders to address this gap in the current clinical practice of balloon pulmonary angioplasty. We summarize the current status of the procedure and provide a consensus opinion on the role of balloon pulmonary angioplasty in the overall care of patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension. We also identify knowledge gaps, provide guidance for new centers interested in initiating balloon pulmonary angioplasty programs, and highlight future directions and research needs for this emerging therapy.
引用
- Aggarwal V, Giri J, Visovatti SH, et al. Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association. Circulation. 2024. PMID: 38450477. doi:10.1161/CIR.0000000000001197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。